CSGP vs CTNM · P/E 484, rev $1.82B vs $429.6M cap
CoStar Group Inc (CSGP) versus Contineum Therapeutics, Inc. Class A Common Stock (CTNM) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Latest reported CSGP revenue for 2026-06-30 was $1.82B. Net income was $58.0M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. CTNM currently screens at market cap $429.6M.
Not investment advice. Open the CSGP and CTNM stock pages for the full models.
Not investment advice.